Top Industry Leaders in the Ischemic Stroke Market
Royal Philips Showcases Latest Technologies at Stroke Conferences: In October 2023, Philips presented advanced imaging solutions and robotic platforms designed to streamline diagnosis and treatment during the crucial "golden hour" after an ischemic stroke
Stryker's Trevoโข Retriever Earns European Approval for Large Vessel Blockages: This January 2024 milestone expands access to a potentially life-saving mechanical thrombectomy device across Europe for patients with complex clots.
Positive Phase 2 Results for AstraZeneca's ASP7378: This December 2023 study suggests the potential of ASP7378 for protecting brain tissue after an ischemic stroke, paving the way for further research and development.
Regen Therapeutics Initiates Phase 3 Trial for Stroke Recovery Stem Cell Therapy: This January 2024 development marks a significant step towards potentially improving functional outcomes in stroke patients through regenerative medicine.
Brainomix Secures FDA Marketing Authorization for e-Stroke Score: This November 2023 approval enables healthcare professionals to utilize this AI-powered platform for rapid stroke diagnosis and treatment decision support.
List ofย Ischemic Strokeย Key companies in the market- GlaxoSmithKline plc (U.K)
- Eli Lilly and Company (U.S.)
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb (U.S.)
- Switzerland) Inc. (U.S.)
- Johnson & Johnson Services Inc. (U.S.)